US Stock MarketDetailed Quotes

DUOPHARMA BIOTECH BERHAD (DUPBF)

Watchlist
  • 0.000
  • 0.0000.00%
15min DelayClose Apr 24 09:30 ET
0Market Cap0.00P/E (TTM)

DUOPHARMA BIOTECH BERHAD (DUPBF) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
14.50%931.69M
16.01%224.69M
6.59%222.49M
1.58%221.78M
36.16%262.74M
15.46%813.7M
15.62%193.67M
23.34%208.73M
30.33%218.32M
-3.74%192.97M
Operating revenue
14.50%931.69M
16.01%224.69M
6.59%222.49M
1.58%221.78M
36.16%262.74M
15.46%813.7M
15.62%193.67M
23.34%208.73M
30.33%218.32M
-3.74%192.97M
Cost of revenue
11.01%568.56M
8.89%128.63M
-0.15%131.74M
-3.25%138.73M
42.76%169.45M
17.36%512.16M
5.42%118.13M
25.95%131.94M
41.06%143.39M
0.64%118.7M
Gross profit
20.43%363.14M
27.16%96.05M
18.17%90.74M
10.83%83.05M
25.61%93.29M
12.38%301.54M
36.24%75.54M
19.10%76.79M
13.77%74.94M
-10.02%74.27M
Operating expense
13.10%228.81M
24.57%66.89M
10.71%56.18M
8.31%51.57M
12.02%54.71M
9.06%202.32M
20.88%53.7M
6.21%50.75M
5.24%47.61M
-6.39%48.83M
Selling and administrative expenses
12.19%226.65M
21.63%65.3M
10.09%56.11M
8.03%51.42M
13.28%54.76M
10.56%202.02M
19.67%53.68M
12.60%50.97M
6.97%47.6M
-7.39%48.34M
-Selling and marketing expense
8.83%129.37M
-0.77%33.45M
12.33%33.07M
15.51%30.91M
10.35%31.98M
14.47%118.88M
39.43%33.71M
11.61%29.44M
14.17%26.76M
-2.98%28.98M
-General and administrative expense
17.01%97.28M
59.41%31.85M
7.02%23.04M
-1.58%20.51M
17.66%22.78M
5.42%83.14M
-3.43%19.98M
13.98%21.53M
-1.04%20.84M
-13.28%19.36M
Other operating expenses
239.18%2.48M
4,157.89%1.62M
54.02%268K
235.19%181K
-97.20%16K
-76.57%730K
--38K
-93.14%174K
-93.04%54K
6,244.44%571K
Operating profit
35.38%134.33M
33.51%29.16M
32.70%34.56M
15.21%31.48M
51.69%38.58M
19.81%99.22M
98.17%21.84M
56.01%26.04M
32.46%27.33M
-16.24%25.44M
Net non-operating interest income expense
8.45%-18.88M
3.25%-4.26M
11.68%-4.88M
8.72%-4.9M
9.15%-4.85M
-33.53%-20.63M
-10.33%-4.4M
-4.88%-5.52M
-30.42%-5.37M
-156.86%-5.34M
Non-operating interest income
-1.59%5.87M
5.99%1.52M
5.67%1.53M
-2.87%1.42M
-13.64%1.4M
116.91%5.97M
0.91%1.44M
268.62%1.45M
198.98%1.47M
264.04%1.62M
Non-operating interest expense
-6.24%24.16M
-0.98%5.78M
-8.08%6.41M
-7.46%6.32M
-10.19%6.25M
45.77%25.77M
7.85%5.84M
23.15%6.97M
48.35%6.83M
175.77%6.96M
Total other finance cost
-28.05%590K
----
----
----
----
58.61%820K
----
----
----
----
Other net income (expense)
Special income (charges)
-137.25%-533K
----
----
----
----
134.91%1.43M
----
----
----
----
-Write off
137.25%533K
----
----
----
----
-134.91%-1.43M
----
----
----
----
Income before tax
43.59%114.91M
42.79%24.91M
44.65%29.68M
21.06%26.58M
67.84%33.74M
26.49%80.02M
147.98%17.44M
79.57%20.52M
32.97%21.96M
-28.95%20.1M
Income tax
57.93%27.45M
148.22%5.86M
44.39%7.11M
21.04%6.38M
67.85%8.1M
63.61%17.38M
260.76%2.36M
100.45%4.93M
32.64%5.27M
-14.76%4.82M
Net income
39.62%87.46M
26.29%19.05M
44.73%22.57M
21.06%20.2M
67.83%25.64M
19.00%62.65M
77.41%15.08M
73.86%15.6M
33.08%16.69M
-32.50%15.28M
Net income continuous Operations
39.62%87.46M
26.29%19.05M
44.73%22.57M
21.06%20.2M
67.83%25.64M
19.00%62.65M
77.41%15.08M
73.86%15.6M
33.08%16.69M
-32.50%15.28M
Minority interest income
0
0
0
0
0
0
0
0
0
0
Net income attributable to the parent company
39.62%87.46M
26.29%19.05M
44.73%22.57M
21.06%20.2M
67.83%25.64M
19.00%62.65M
77.41%15.08M
73.86%15.6M
33.08%16.69M
-32.50%15.28M
Preferred stock dividends
Other preferred stock dividends
0
0
0
0
0
0
0
0
0
0
Net income attributable to common stockholders
39.62%87.46M
26.29%19.05M
44.73%22.57M
21.06%20.2M
67.83%25.64M
19.00%62.65M
77.41%15.08M
73.86%15.6M
33.08%16.69M
-32.50%15.28M
Basic earnings per share
39.63%0.0909
26.11%0.0198
45.06%0.0235
21.39%0.021
67.92%0.0267
18.58%0.0651
78.41%0.0157
74.19%0.0162
32.06%0.0173
-33.19%0.0159
Diluted earnings per share
39.63%0.0909
26.11%0.0198
45.06%0.0235
21.39%0.021
67.92%0.0267
18.58%0.0651
78.41%0.0157
74.19%0.0162
32.06%0.0173
-33.19%0.0159
Dividend per share
0.015
0
0.015
Currency Unit
MYR
MYR
MYR
MYR
MYR
MYR
MYR
MYR
MYR
MYR
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 14.50%931.69M16.01%224.69M6.59%222.49M1.58%221.78M36.16%262.74M15.46%813.7M15.62%193.67M23.34%208.73M30.33%218.32M-3.74%192.97M
Operating revenue 14.50%931.69M16.01%224.69M6.59%222.49M1.58%221.78M36.16%262.74M15.46%813.7M15.62%193.67M23.34%208.73M30.33%218.32M-3.74%192.97M
Cost of revenue 11.01%568.56M8.89%128.63M-0.15%131.74M-3.25%138.73M42.76%169.45M17.36%512.16M5.42%118.13M25.95%131.94M41.06%143.39M0.64%118.7M
Gross profit 20.43%363.14M27.16%96.05M18.17%90.74M10.83%83.05M25.61%93.29M12.38%301.54M36.24%75.54M19.10%76.79M13.77%74.94M-10.02%74.27M
Operating expense 13.10%228.81M24.57%66.89M10.71%56.18M8.31%51.57M12.02%54.71M9.06%202.32M20.88%53.7M6.21%50.75M5.24%47.61M-6.39%48.83M
Selling and administrative expenses 12.19%226.65M21.63%65.3M10.09%56.11M8.03%51.42M13.28%54.76M10.56%202.02M19.67%53.68M12.60%50.97M6.97%47.6M-7.39%48.34M
-Selling and marketing expense 8.83%129.37M-0.77%33.45M12.33%33.07M15.51%30.91M10.35%31.98M14.47%118.88M39.43%33.71M11.61%29.44M14.17%26.76M-2.98%28.98M
-General and administrative expense 17.01%97.28M59.41%31.85M7.02%23.04M-1.58%20.51M17.66%22.78M5.42%83.14M-3.43%19.98M13.98%21.53M-1.04%20.84M-13.28%19.36M
Other operating expenses 239.18%2.48M4,157.89%1.62M54.02%268K235.19%181K-97.20%16K-76.57%730K--38K-93.14%174K-93.04%54K6,244.44%571K
Operating profit 35.38%134.33M33.51%29.16M32.70%34.56M15.21%31.48M51.69%38.58M19.81%99.22M98.17%21.84M56.01%26.04M32.46%27.33M-16.24%25.44M
Net non-operating interest income expense 8.45%-18.88M3.25%-4.26M11.68%-4.88M8.72%-4.9M9.15%-4.85M-33.53%-20.63M-10.33%-4.4M-4.88%-5.52M-30.42%-5.37M-156.86%-5.34M
Non-operating interest income -1.59%5.87M5.99%1.52M5.67%1.53M-2.87%1.42M-13.64%1.4M116.91%5.97M0.91%1.44M268.62%1.45M198.98%1.47M264.04%1.62M
Non-operating interest expense -6.24%24.16M-0.98%5.78M-8.08%6.41M-7.46%6.32M-10.19%6.25M45.77%25.77M7.85%5.84M23.15%6.97M48.35%6.83M175.77%6.96M
Total other finance cost -28.05%590K----------------58.61%820K----------------
Other net income (expense)
Special income (charges) -137.25%-533K----------------134.91%1.43M----------------
-Write off 137.25%533K-----------------134.91%-1.43M----------------
Income before tax 43.59%114.91M42.79%24.91M44.65%29.68M21.06%26.58M67.84%33.74M26.49%80.02M147.98%17.44M79.57%20.52M32.97%21.96M-28.95%20.1M
Income tax 57.93%27.45M148.22%5.86M44.39%7.11M21.04%6.38M67.85%8.1M63.61%17.38M260.76%2.36M100.45%4.93M32.64%5.27M-14.76%4.82M
Net income 39.62%87.46M26.29%19.05M44.73%22.57M21.06%20.2M67.83%25.64M19.00%62.65M77.41%15.08M73.86%15.6M33.08%16.69M-32.50%15.28M
Net income continuous Operations 39.62%87.46M26.29%19.05M44.73%22.57M21.06%20.2M67.83%25.64M19.00%62.65M77.41%15.08M73.86%15.6M33.08%16.69M-32.50%15.28M
Minority interest income 0000000000
Net income attributable to the parent company 39.62%87.46M26.29%19.05M44.73%22.57M21.06%20.2M67.83%25.64M19.00%62.65M77.41%15.08M73.86%15.6M33.08%16.69M-32.50%15.28M
Preferred stock dividends
Other preferred stock dividends 0000000000
Net income attributable to common stockholders 39.62%87.46M26.29%19.05M44.73%22.57M21.06%20.2M67.83%25.64M19.00%62.65M77.41%15.08M73.86%15.6M33.08%16.69M-32.50%15.28M
Basic earnings per share 39.63%0.090926.11%0.019845.06%0.023521.39%0.02167.92%0.026718.58%0.065178.41%0.015774.19%0.016232.06%0.0173-33.19%0.0159
Diluted earnings per share 39.63%0.090926.11%0.019845.06%0.023521.39%0.02167.92%0.026718.58%0.065178.41%0.015774.19%0.016232.06%0.0173-33.19%0.0159
Dividend per share 0.01500.015
Currency Unit MYRMYRMYRMYRMYRMYRMYRMYRMYRMYR
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More